The Effect of Vitamin D and Exercise on Balance in Postmenopausal Women
1 other identifier
interventional
110
1 country
1
Brief Summary
In recent years, skeletal and nonskeletal effects of vitamin D has been studied. One of the effects of it was balance and fall prevention. However, these studies were performed on older patients who had not vitamin D deficiency. This study aimed to evaluate the effect of vitamin D replacement therapy and exercise on balance in 50-70 years-old postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2018
CompletedFirst Posted
Study publicly available on registry
August 1, 2018
CompletedStudy Start
First participant enrolled
August 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2019
CompletedResults Posted
Study results publicly available
February 27, 2020
CompletedJuly 1, 2020
June 1, 2020
11 months
July 4, 2018
September 22, 2019
June 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postural Stability Test (Biodex) Assessed at Baseline
overall stability index: quantifying the ability to maintain dynamic postural stability The patient's score on this test assesses deviations from center, thus lower index means less instability and better balance. Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System. 0 is the minimum score, but there is no defined maximum score
Baseline
Postural Stability Test (Biodex) Assessed After Treatment (8 Weeks)
overall stability index: quantifying the ability to maintain dynamic postural stability. The patient's score on this test assesses deviations from center, thus a lower score is more desirable than a higher score. Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System 0 is the minimum score, but there is no defined maximum score
After treatment (8 weeks)
Berg Balance Test Assessed at Baseline
14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of \< 45 indicates individuals may be at greater risk of falling.
Baseline
Berg Balance Test Assessed After Treatment (8weeks)
14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of \< 45 indicates individuals may be at greater risk of falling.
After treatment (8 weeks)
Secondary Outcomes (4)
Fall Risk Assesment Performed at Baseline
Baseline
Fall Risk Assesment Performed After Treatment (8 Weeks)
After treatment (8 weeks)
Health Status Assessed at Baseline
Baseline
Health Status Assessed After Treatment (8 Weeks)
After treatment (8 weeks)
Study Arms (4)
Vitamin D<10 ng/ml; Vitamin D replacement
EXPERIMENTALVitamin D replacement (50.000 IU/per week, for 8 weeks)
Vitamin D<10 ng/ml; Vitamin D replacement and exercise
EXPERIMENTALVitamin D replacement (50.000 IU/per week, for 8 weeks) and Core and balance exercises for 8 weeks.
Vitamin D<10 ng/ml; exercise
EXPERIMENTALCore and balance exercises for 8 weeks.
Vitamin D>30ng/ml; exercise
ACTIVE COMPARATORCore and balance exercises for 8 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- years-old postmenopausal women
- Vitamin D level\<10 ng/ml and Vitamin D level\>30 ng/ml
- Independant in daily life
- Able to do exercise
- Able to read and write in Turkish
You may not qualify if:
- Diabetes mellitus,
- Polyneuropathy,
- Spinal stenosis,
- History of fracture or lower extremity operation,
- Rheumatologic diseases,
- History of chemotherapy
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan Abdulhamid Han Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Tugba OZsoy-Unubol
- Organization
- SultanAbdulhamid
Study Officials
- PRINCIPAL INVESTIGATOR
Tugba Ozsoy-Unubol, MD
Sultan Abdulhamid Han Training and Research Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2018
First Posted
August 1, 2018
Study Start
August 6, 2018
Primary Completion
July 12, 2019
Study Completion
July 12, 2019
Last Updated
July 1, 2020
Results First Posted
February 27, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share